Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP).
Fujitani Y, Fujimoto S, Takahashi K, Satoh H, Hirose T, Hiyoshi T, Ai M, Okada Y, Gosho M, Mita T, Watada H. Fujitani Y, et al. Among authors: gosho m. Diabetes Res Clin Pract. 2016 Nov;121:146-156. doi: 10.1016/j.diabres.2016.09.014. Epub 2016 Sep 22. Diabetes Res Clin Pract. 2016. PMID: 27710821 Clinical Trial.
Risk Factor Analysis for Type 2 Diabetes Patients About Hypoglycemia Using Continuous Glucose Monitoring: Results from a Prospective Observational Study.
Uemura F, Okada Y, Mita T, Torimoto K, Wakasugi S, Katakami N, Yoshii H, Matsushita K, Nishida K, Inokuchi N, Tanaka Y, Gosho M, Shimomura I, Watada H. Uemura F, et al. Among authors: gosho m. Diabetes Technol Ther. 2022 Jun;24(6):435-445. doi: 10.1089/dia.2021.0465. Epub 2022 Feb 15. Diabetes Technol Ther. 2022. PMID: 35049378
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).
Mita T, Katakami N, Yoshii H, Onuma T, Kaneto H, Osonoi T, Shiraiwa T, Kosugi K, Umayahara Y, Yamamoto T, Yokoyama H, Kuribayashi N, Jinnouchi H, Gosho M, Shimomura I, Watada H; Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Trial. Mita T, et al. Among authors: gosho m. Diabetes Care. 2016 Jan;39(1):139-48. doi: 10.2337/dc15-0781. Epub 2015 Dec 1. Diabetes Care. 2016. PMID: 26628419 Clinical Trial.
165 results